Article

Antioxidant and antileukemic properties of selected fenugreek (Trigonella foenum-graecum L.) genotypes grown in western Canada

Agriculture and Agri-Food Canada Research Centre, T1J 4B1, Lethbridge, Alberta, Canada; Department of Botany, University of Calcutta, Kolkata; WB India 700018; Laboratory of Experimental Immunology, Department of Botany, Gurudas College, Kolkata; WB India 700054; Department of Biological Sciences, University of Lethbridge, T1K 3M4, Lethbridge, Alberta, Canada
Canadian Journal of Plant Science (Impact Factor: 0.92). 01/2011; 91(1). DOI: 10.4141/cjps10025

ABSTRACT 2011. Antioxidant and antileukemic properties of selected fenugreek (Trigonella foenum-graecum L.) genotypes grown in western Canada. Can. J. Plant Sci. 91: 99Á105. Fenugreek (Trigonella foenum-graecum L.) is an annual forage legume known to have a number of important medicinal properties such as being anti-diabetic and hyperchloesterolaemic among others. In this study we have investigated the anti-oxidant and antileukemic properties of five fenugreek genotypes (L3068, L3375, Tristar, PI143504 and Amber) grown in western Canada for their potential use as nutraceuticals. Our preliminary experiments conducted in two different laboratories showed that the seeds grown in western Canada have anti-oxidant and antileukemic properties and the genotypes differ in the two traits studied. All the genotypes were found to be good scavengers for hydroxyl and free radicals. Among all the varieties, L3068 showed a higher EC 50 value i.e., lower inhibitory activity for lipid peroxidation than the standard catechin. Although all five extracts showed significant antioxidant activity, the crude extract of Tristar was the most effective. Out of the five cultivars of fenugreek, Amber and L3375 showed a robust antileukemic activity followed by Tristar. Hence we conclude that Tristar has the best potential among all the genotypes tested to be used as a future nutraceutical crop when grown in western Canada.

2 Bookmarks
 · 
101 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of the present study was to evaluate the protective effect of trigonelline (TRIG) and sitagliptin (SITA) combination in streptozotocin-nicotinamide induced diabetes in Wistar rats. Diabetes was induced by streptozotocin (65 mg/kg i.p.) injected 15 min after nicotinamide (110 mg/kg, i.p.). The rats were divided into following groups: Group 1: non-diabetic control, Group 2: diabetic control (saline), Groups 3, 4, 5 received TRIG as 25, 50, 100 mg/kg p.o., Groups 6, 7, 8 received SITA as 2.5, 5, 10 mg/kg p.o. respectively. For acute study, serum glucose (SG) levels were measured at 0, 2nd, 4th, 6th and 24th hour after administration. To find out effective combination, acute study of TRIG + SITA combination was done. The doses used are in combination TRIG + SITA as Groups 9, 10, 11 as 70% + 30%, 50% + 50%, 30 + 70%. SG was measured as per above-mentioned pattern. A 28-day subacute study was performed by taking effective percentage combination of TRIG + SITA. For subacute study SG, body weight was measured on 7th, 14th, 21st, 28th day; while serum insulin, HbA1c and pancreatic histopathological study were done on 28th day. In acute study, TRIG + SITA (50% + 50%) were more effectively 43.08% reduction in SG level at 6 h with onset at 2 h and effect waned at 24 h. Subacute study reveals that the TRIG + SITA (50% + 50%) reduces SG by 54.72% than alone on 28th day. Serum insulin levels, body weight, pancreatic mass were increased with reduction in HbA1c levels in animals receiving 50% + 50% combination of TRIG + SITA. The concomitant administration of TRIG + SITA (50% + 50%) contributes in the prevention to development diabetes and showed synergistic antihyperglycemic effect.
    Biomedicine & Aging Pathology. 07/2013; 3(3):125–130.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fenugreek (Trigonella foenum-graecum L.) is an annual, bloat-free, forage legume and is currently grown in the continents of west, south and south-east Asia, North Africa, Mediterranean Europe, Australia, and North America. In addition to its use as a forage crop, it is most widely known all over the world as an aromatic and spice crop with a number of medicinal properties. The plant is an important source of essential phytochemicals such as steroidal sapogenins, galacatomannans, 4-hydroxyisoleucine, antioxidants to name only a few. Fenugreek has been extensively studied for its role in treatment of diabetes and hypercholesterolaemia, both in traditional medicinal practices as well as in modern drug based medicinal applications. However, this species is not much known or widely cultivated in Latin America, although suitable arid to semiarid, rainfed agro-climatic conditions are available. Furthermore, has remained unknown or less known to farmers, producers, breeders and crop and forage researchers in Latin America. This is the first comprehensive review to introduce fenugreek as potential forage crop for Latin America and has been suggested how it could be made into a regular crop under agro-pastoral systems. The following review highlights the crop, its botanical status and in depth discussion of the crop agronomy, breeding, genetics, medicinal properties with particular emphasis on its seeds in the control of Diabetes Mellitus.
    Trames Journal of the Humanities and Social Sciences 05/2014; 4(3):145-161. · 0.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fenugreek (Trigonella foenum-graecum L.) is an annual, bloat-free, forage legume and is currently grown in the continents of west, south and south-east Asia, North Africa, Mediterranean Europe, Australia, and North America. In addition to its use as a forage crop, it is most widely known all over the world as an aromatic and spice crop with a number of medicinal properties. The plant is an important source of essential phytochemicals such as steroidal sapogenins, galacatomannans, 4-hydroxyisoleucine, antioxidants to name only a few. Fenugreek has been extensively studied for its role in treatment of diabetes and hypercholesterolaemia, both in traditional medicinal practices as well as in modern drug based medicinal applications. However, this species is not much known or widely cultivated in Latin America, although suitable arid to semiarid, rainfed agro-climatic conditions are available. Furthermore, has remained unknown or less known to farmers, producers, breeders and crop and forage researchers in Latin America. This is the first comprehensive review to introduce fenugreek as potential forage crop for Latin America and has been suggested how it could be made into a regular crop under agro-pastoral systems. The following review highlights the crop, its botanical status and in depth discussion of the crop agronomy, breeding, genetics, medicinal properties with particular emphasis on its seeds in the control of Diabetes Mellitus.
    American Journal of Social Issues and Humanities. 05/2014; 4(3):145-162.

Full-text (2 Sources)

Download
290 Downloads
Available from
Jun 1, 2014